Introduction
Streptococcus pneumoniae (SPn) is one of the major bacterial pathogens colonising the nasopharynx, which can cause a wide spectrum of illnesses from upper respiratory tract infection (RTI) to invasive pneumococcal disease (IPD), or the infection can be asymptomatic [1] . SPn infection is also associated with high mortalityan estimated 1.6 million people, including 0.7-1 million children under five years of age, die of pneumococcal diseases each year worldwide [2] .
Pneumococcal disease is preceded by asymptomatic colonisation: the colonisation rate is especially high in children under six years of age [1, 3] . In addition, nasopharyngeal carriage is a major factor in the horizontal transmission of SPn strains and nasopharyngeal isolates reflect currently circulating strains in the community [4] . Young children are thought to be the most important source in horizontal dissemination of pneumococcal strains due to the high frequency of pneumococcal colonisation and high crowding in day-care centres and families [1] .
There is a wide variation in SPn capsule polysaccharides: currently 94 serotypes have been identified [5] . Different SPn serotypes have different propensities to cause disease [6] . The distribution of SPn serotypes varies by country, age or ethnic group, and study design [4, [7] [8] [9] [10] [11] [12] [13] . Data on distribution of SPn serotypes among children in Lithuania are limited. The National Public Health Surveillance Laboratory in Vilnius collects all invasive pneumococcus strains nationwide. A total of 45 SPn strains, which caused IPD in children under five years of age, were serotyped during 2006 to 2011. Some 14 different serotypes were identified, with 23F, 14, 6B, 1, 18C being the most prevalent serotypes [14] . As the amount of data was low, however, the findings do not necessarily reflect the actual SPn serotype prevalence among IPD paediatric patients in Lithuania.
The presence of SPn in the nasopharynx of children with acute RTI might be considered as an additional risk factor for development of mucosal or invasive pneumococcal disease [15] ; however, data on the carriage rate and SPn serotype distribution among such patients worldwide are limited. The data in our study will be analysed further to evaluate whether the presence of SPn in the nasopharynx had an influence on the outcome of acute RTI among our patients.
At the time of the study, routine PCV vaccination was not yet part of the national vaccination schedule in Lithuania and PCVs (10-valent (PCV10) and 13-valent (PCV13)) were available only on private market. As vaccination costs were not reimbursed, vaccination coverage was unknown but was probably rather low due to the relatively high price of the vaccines.
The nasopharynx is the reservoir for SPn and the carriage of SPn in children with acute RTI has not been studied widely. This study was undertaken to evaluate the circulation of SPn serotypes among children with acute RTI under six years of age in Lithuania before the introduction of universal pneumococcal vaccination in the country in October 2014 [16] . It was expected that the data collected will be helpful in decision-making regarding universal PCV vaccination in Lithuania. They may also be the basis for further investigations into the impact of PCV vaccination on the distribution of SPn serotypes in Lithuania, including the widely discussed phenomenon of replacement, i.e. changes in circulating SPn serotypes due to vaccination [17] .
Methods
This prospective study was carried out from February 2012 to March 2013. Eight primary care centres in Lithuania's five biggest cities (Vilnius (n = 2), Kaunas (n = 2), Klaipeda (n = 2), Panevezys (n = 1), Alytus (n = 1)), from all main regions of the country, and the emergency department (ED) of Children's Hospital, Affiliate of Vilnius University Hospital Santariskiu Klinikos in Vilnius were involved in examining children for SPn nasopharyngeal carriage.
Children under six years old, who visited a primary care physician because of acute RTI and who met all inclusion criteria were enrolled into the study. The main symptoms of acute RTI were acute onset, fever, runny nose, cough, throat redness and otalgia. Children were excluded if they had been vaccinated with any pneumococcal vaccine, had taken antibiotics during the previous month or another cause of fever was identified (e.g. it was confirmed not due to respiratory infection).
Local ethics committee approval was obtained and the parents were asked to sign an informed consent form before the child was enrolled in the study. Nasopharyngeal swabs were taken at the time of enrolment in the study using Culturette with Amies transport medium (Deltalab, Spain) and transported to the bacteriology laboratory of Children's Hospital, Affiliate of Vilnius University Hospital Santariskiu Klinikos in Vilnius within 48 hours from collection. Classic cultural methods (cultivation in 5% CO 2 , colony morphology, optochin sensitivity) were used to isolate SPn from the swabs [18] . Serotypes were determined by means of latex agglutination reaction using the PneumotestLatex kit (Statens Serum Institut, Copenhagen, Denmark).
Statistical analysis
The data were analysed using SPSS software 16. Chisquared test was used to test statistical significance for differences between two groups. Fisher's exact test was used when cell values in the SPSS table had an expected frequency of five or less. Statistical significance was defined by p < 0.05.
The expected theoretical protection of PCVs was calculated by comparing the isolated SPn serotypes with the serotypes included in currently available PCV vaccines. 
Results
During the one-year study period, 908 children were examined for SPn nasopharyngeal carriage. Due to the exclusion criteria, eight were excluded from the analysis. The data collected from the 900 study participants were analysed: 636 patients at the PCCs and 264 at the hospital ED.
The enrolled children comprised 408 girls and 492 boys under six years of age with acute RTI. The participants were enrolled throughout the study period. Two thirds were enrolled during spring and autumn (35.0% (n = 315) and 32.9% (n = 296), respectively), the others during winter (22.0% (n = 198) and summer (10.1% (n = 91)). The distribution of enrolled children by sex and age was similar in all the cities, with the exception of Alytus (Table) , which may be due to a very small number of study participants in this city (n = 18).
Streptococcus pneumoniae colonisation rate
A total of 367 SPn strains (one per patient) were isolated from the 900 samples collected, giving a colonisation rate of 40.8%. The rate was higher among patients admitted to the ED of the Children's Hospital in Vilnius than among patients at the PCCs (45.8% (121/264) vs 38.7% (246/636); p = 0.047). The colonisation rate was There was also a higher colonisation rate in Vilnius (both PCC and ED) than in Klaipeda (38.1%, 24/63), but the difference was not statistically significant (p = 0.168). The distribution of pneumococcal colonisation rates in the enrolled children in the five cities in Lithuania is shown in Figure 1 .
Seasonality differences were detected in SPn colonisation rates: they were higher in spring ( 
Streptococcus pneumoniae serotype distribution
Of the 367 SPn strains isolated, 22 different serotypes were detected. The most common serotypes were 6B (15.8%, n = 58), 19F (13.9%, n = 51), 23F (13.9%, n = 51), 15 (10.1%, n = 37), 14 (9.5%, n = 35), 6A (9.3%, n = 34), 11 (4.6%, n = 17), 3 (3.0%, n = 11) and 18C (3.0%, n = 11). Other SPn serotypes constituted 16.9% (n = 62) of all isolates and were as follows: serotypes 23 (non-23F) (2.7%, n = 10), 19A (2.2%, n = 8), 9V (1.6%, n = 6), 9 (1.1%, n = 4), 10 (1.1%, n = 4), 22 (0.8%, n = 3), 6C (0.5%, n = 2) and single isolates of 4, 7, 7F, 12, 17 and 19 serotypes; 5.2% (n = 19) were non-typable.
Differences in the distribution of SPn serotypes between those isolated from patients at the Vilnius ED and the PCCs were not statistically significant, except for serotypes 6B and 23, which were more common at the PCCs (p = 0.03 and p = 0.034, respectively) ( Figure  2 ). A slightly different distribution of SPn serotypes was found in the study sites ( Figure 3 Of the 165 isolates from girls, serotypes 6B (20.0%, n = 33), 23F (12.7%, n = 21), 19F (10.9%, n = 18), 15 (10.3%, n = 17), 6A (9.7%,n = 16) and 14 (9.7%, n = 16) were the most common, whereas of the 202 isolates from boys, serotypes 19F (16.3%, n = 33), 23F (14.9%, n = 30), 6B (12.4%, n = 25), 15 (9.9%, n = 20), 14 (9.4%, n = 19) and 6A (8.9%, n = 18) were the most common. There were no sex-related differences, except for 6B, which was more common in girls (p = 0.046).
In addition, the study showed an age-related SPn serotype distribution, with serotypes 6A and 11 being more common in the youngest age group (0-2 years), while 18C was found only in the older age groups (Figure 4 ).
Among all serotypes isolated from our 367 patients, 58% (n = 214) were present in PCV10 (serotypes 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F and 23F) and 73% (n = 267) in PCV13 (serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F).
Discussion
Data concerning the SPn nasopharyngeal carriage rates among healthy children in eastern Europe, including Lithuania, are limited. During the last decades, a number of studies on SPn nasopharyngeal carriage in healthy children were performed in western and southern Europe, with carriage rates ranging from 14.9% to 58.5% [8, 10, 11, 13] . The reported rates of pneumococcal carriage among healthy children under eight years of age varied, with a wide range from 3.5% to 97% among different studies worldwide [19, 20] . Surprisingly low carriage rates (3.5-14.9%) were observed in a few Italian studies performed in 1996 and 1999 [10, 19] , whereas much higher rates were seen in Romania (51% during 2008-09) [12] , France (54% in 1999) [8] , Russia (60% in 2007) [21] and Norway (77.7% in 2006) [22] . The highest SPn carriage rates among healthy children (70-97%) have been found in some Asian and African countries, e.g. in India (70.2% in 1998-99) [23] , Gambia (97% in 2004-06) [20] and Malawi (84% in 1997) [24] . In Mozambique in 2003, SPn carriage was more common among children who had lower RTI symptoms at the time of enrolment (93%) than among healthy children (84%) [25] .
Three studies of SPn nasopharyngeal carriage in healthy children have been performed in Lithuania (in 1999, 2001 and 2006) [26] [27] [28] , in which a total of 1,625 children from the same 13 day-care centres were enrolled. On average, SPn was found in the nasopharynx of every second child (51% in 1999, 55% in 2001 and 43% in 2006) and the most prevalent serotypes were 19F, 23F, 6B, 6A, 3 and 18C. These studies were rather limited because all of them were performed during a short period of time (in February and March) and the data presented were from only one city of the country (Vilnius).
In our findings presented here, the SPn colonisation rate among young children with acute RTI in the study sites in Lithuania was 40.8%. It is important to note that most studies have focused on SPn carriage in healthy children while in our study, children with RTI were enrolled. The carriage rate seen was similar to those observed in healthy children in Estonia (44%), Czech Republic (38.1%) and Hungary (37.71%) [9, 29, 30] . It is also similar to those reported in healthy children in Vilnius in 2006 (43%) and slightly lower than that in 1999 and 2001 (51% and 55%, respectively) [26] [27] [28] . showed that nasopharyngeal SPn carriage rates increased during respiratory infections from 13-43% to 45-56%, depending on age [32] . It has also been shown that the SPn carriage rate during the first days of acute RTI is comparable to that in healthy children [33] . However, in RTI patients carrying SPn, a more severe course of RTI or activation of pneumococcal disease can occur and this is a subject for further analysis of our data.
Commonly, SPn nasopharyngeal colonisation begins in infancy, with peak incidence occurring at two to three years of age and decreases among children over the age of four to five years [12, 13, 20] . [20, 23, 34] , in contrast to Finland, where only 9-22% of infants were colonised by SPn (1994-97) [32] .
We found a seasonal fluctuation in the rates of SPn nasopharyngeal colonisation, with an increase during spring and autumn. Similarly, spring appeared to be a favourable season for SPn colonisation in comparison to winter in Poland [35] or winter in the United States [36] . In contrast, there was a reported increase of pneumococcal carriage in winter in Israel [37] . Other studies have found the seasonal effect to be negligible or absent [38, 39] . Social factors such as being longer inside in day-care centres and higher crowding during the winter season or higher air pollution can be speculated as additional factors leading to higher colonisation rates.
In our study, the most predominant colonising serotypes were 6B, 19F, 23F [26, 27] and 10% in our study. The distribution of other SPn serotypes remained stable, with small differences in their rates. It is important to note, however, that the study sites and the type of children studied differed, which limit the comparison.
Although the data on SPn serotypes in children with IPD in Lithuania are rather limited, we have tried to compare the serotype distribution among IPD patients and nasopharyngeal carriers. Serotypes 23F, 14, 6B, commonly found in the nasopharynx in our study, were the most prevalent among all SPn isolates from children with IPD identified during 2006 to 2011 in Lithuania [14] . Serotypes 1 and 18C each constituted 8.9% of the invasive isolates [14] , 18C was three times less common (3.0%, 11/367) and serotype 1 was absent in nasopharyngeal carriage in our study. According to data reported by other authors, serotype 1 is among the most commonly isolated serotypes in IPD but it is rarely found among nasopharyngeal carriers [40] .
Age-related differences of pneumococcal serotype distribution were found in our study, with serotypes 6A and 11 being more common in the youngest children, while 18C was found only in the older age groups. A study conducted by Bogaert et al. in 2002 showed an age-related serotype distribution in healthy children in the Netherlands, with a primary peak of serotypes included in the seven-valent conjugate vaccine (PCV-7) at the age of one year, followed by a secondary peak of non-vaccine serotypes at the age of four years [13] . However, few data are available concerning SPn serotype distribution in the nasopharynx according to age.
The serotypes found in a population might be an important predictor of the likely effectiveness of a pneumococcal vaccine in that population. Our findings suggest a rather high theoretical coverage (58-73%) of nasopharyngeal pneumococcal isolates by the currently available PCVs (PCV-10 and PCV-13 [4, 8, 12] .
As our study was performed before the implementation of the universal programme of PCV vaccination in Lithuania, it provides a basis for future comparisons of SPn carriage and serotype distribution between the pre-and post-vaccination era in the country.
